Literature DB >> 2374685

Autosomal-dominant fundus flavimaculatus. Clinicopathologic correlation.

P F Lopez1, I H Maumenee, Z de la Cruz, W R Green.   

Abstract

The authors report the first clinicopathologic study of autosomal-dominant fundus flavimaculatus with late-onset atrophic macular degeneration in a 62-year-old man. Results of histopathologic examination disclosed the retinal pigment epithelium (RPE) to be distended by a periodic acid-Schiff (PAS)-positive, acid mucopolysaccharide-negative material. Transmission electron microscopy showed marked accumulation of lipofuscin and melanolipofuscin granules within the RPE. The different modes of genetic transmission and ultrastructural heterogeneity suggest that fundus flavimaculatus is a clinical syndrome representing several genetically and mechanistically distinct disorders whose common end-stage is a topographically similar accumulation of lipofuscin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2374685     DOI: 10.1016/s0161-6420(90)32508-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  35 in total

1.  Reproducibility of fundus autofluorescence measurements obtained using a confocal scanning laser ophthalmoscope.

Authors:  N Lois; A S Halfyard; C Bunce; A C Bird; F W Fitzke
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

2.  Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease.

Authors:  N Lois; A S Halfyard; A C Bird; F W Fitzke
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

3.  Therapy for macular degeneration: insights from acne.

Authors:  Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 4.  Keypathophysiologic pathways in age-related macular disease.

Authors:  Felix Roth; Almut Bindewald; Frank G Holz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

5.  Fundus flavimaculatus and subretinal neovascularization.

Authors:  F Bottoni; G Fatigati; G Carlevaro; V De Molfetta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

6.  Color vision in Stargardt's disease.

Authors:  M Mäntyjärvi; K Tuppurainen
Journal:  Int Ophthalmol       Date:  1992-11       Impact factor: 2.031

7.  Multifocal electroretinography in patients with Stargardt's macular dystrophy.

Authors:  U Kretschmann; M W Seeliger; K Ruether; T Usui; E Apfelstedt-Sylla; E Zrenner
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 8.  Molecular genetics of macular dystrophies.

Authors:  K Zhang; H Yeon; M Han; L A Donoso
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

9.  Choroidal binarization analysis: clinical application.

Authors:  Sara Crisostomo; Joana Cardigos; Diogo Hipólito Fernandes; Maria Elisa Luís; Ricardo Figueiredo; Nuno Moura-Coelho; João Paulo Cunha; Luís Abegão Pinto; Joana Ferreira
Journal:  Int Ophthalmol       Date:  2019-05-28       Impact factor: 2.031

10.  Assessment of the interphotoreceptor matrix proteoglycan-1 (IMPG1) gene localised to 6q13-q15 in autosomal dominant Stargardt-like disease (ADSTGD), progressive bifocal chorioretinal atrophy (PBCRA), and North Carolina macular dystrophy (MCDR1).

Authors:  A Gehrig; U Felbor; R E Kelsell; D M Hunt; I H Maumenee; B H Weber
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.